These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 25240056)
21. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Assmus B; Schächinger V; Teupe C; Britten M; Lehmann R; Döbert N; Grünwald F; Aicher A; Urbich C; Martin H; Hoelzer D; Dimmeler S; Zeiher AM Circulation; 2002 Dec; 106(24):3009-17. PubMed ID: 12473544 [TBL] [Abstract][Full Text] [Related]
22. Intracoronary versus intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: 6-month effects on infarct size and left ventricular function. The randomised Leipzig Immediate PercutaneouS Coronary Intervention Abciximab i.v. versus i.c. in ST-Elevation Myocardial Infarction Trial (LIPSIAbciximab-STEMI). Eitel I; Friedenberger J; Fuernau G; Dumjahn A; Desch S; Schuler G; Thiele H Clin Res Cardiol; 2011 May; 100(5):425-32. PubMed ID: 21125288 [TBL] [Abstract][Full Text] [Related]
23. Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. Gallet R; Dawkins J; Valle J; Simsolo E; de Couto G; Middleton R; Tseliou E; Luthringer D; Kreke M; Smith RR; Marbán L; Ghaleh B; Marbán E Eur Heart J; 2017 Jan; 38(3):201-211. PubMed ID: 28158410 [TBL] [Abstract][Full Text] [Related]
24. A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model. Ichimura K; Matoba T; Nakano K; Tokutome M; Honda K; Koga J; Egashira K PLoS One; 2016; 11(9):e0162425. PubMed ID: 27603665 [TBL] [Abstract][Full Text] [Related]
25. Acute Myocardial Infarction with Hyperoxemic Therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention. O'Neill WW; Martin JL; Dixon SR; Bartorelli AL; Trabattoni D; Oemrawsingh PV; Atsma DE; Chang M; Marquardt W; Oh JK; Krucoff MW; Gibbons RJ; Spears JR; J Am Coll Cardiol; 2007 Jul; 50(5):397-405. PubMed ID: 17662390 [TBL] [Abstract][Full Text] [Related]
26. Heat shock protein 47 (HSP47) antisense oligonucleotides reduce cardiac remodeling and improve cardiac function in a rat model of myocardial infarction. Hagiwara S; Iwasaka H; Shingu C; Matumoto S; Hasegawa A; Noguchi T Thorac Cardiovasc Surg; 2011 Oct; 59(7):386-92. PubMed ID: 21412710 [TBL] [Abstract][Full Text] [Related]
27. Evolution of reperfusion post-infarction ventricular remodeling: new MRI insights. Springeling T; Uitterdijk A; Rossi A; Gorsse-Bakker C; Wielopolski PA; van der Giessen WJ; Krestin GP; de Feyter PJ; Duncker DJ; van Geuns RJ Int J Cardiol; 2013 Nov; 169(5):354-8. PubMed ID: 24182681 [TBL] [Abstract][Full Text] [Related]
28. Analysis of Cell Type-Specific Effects of MicroRNA-92a Provides Novel Insights Into Target Regulation and Mechanism of Action. Rogg EM; Abplanalp WT; Bischof C; John D; Schulz MH; Krishnan J; Fischer A; Poluzzi C; Schaefer L; Bonauer A; Zeiher AM; Dimmeler S Circulation; 2018 Nov; 138(22):2545-2558. PubMed ID: 30571345 [TBL] [Abstract][Full Text] [Related]
29. Effect of reperfusion on left ventricular regional remodeling strains after myocardial infarction. Sakamoto H; Parish LM; Hamamoto H; Ryan LP; Eperjesi TJ; Plappert TJ; Jackson BM; St John-Sutton MG; Gorman JH; Gorman RC Ann Thorac Surg; 2007 Nov; 84(5):1528-36. PubMed ID: 17954057 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-145 repairs infarcted myocardium by accelerating cardiomyocyte autophagy. Higashi K; Yamada Y; Minatoguchi S; Baba S; Iwasa M; Kanamori H; Kawasaki M; Nishigaki K; Takemura G; Kumazaki M; Akao Y; Minatoguchi S Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1813-26. PubMed ID: 26432843 [TBL] [Abstract][Full Text] [Related]
31. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Britten MB; Abolmaali ND; Assmus B; Lehmann R; Honold J; Schmitt J; Vogl TJ; Martin H; Schächinger V; Dimmeler S; Zeiher AM Circulation; 2003 Nov; 108(18):2212-8. PubMed ID: 14557356 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA-208a Increases Myocardial Endoglin Expression and Myocardial Fibrosis in Acute Myocardial Infarction. Shyu KG; Wang BW; Cheng WP; Lo HM Can J Cardiol; 2015 May; 31(5):679-90. PubMed ID: 25936493 [TBL] [Abstract][Full Text] [Related]
33. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction. Nyolczas N; Gyöngyösi M; Beran G; Dettke M; Graf S; Sochor H; Christ G; Edes I; Balogh L; Krause KT; Jaquet K; Kuck KH; Benedek I; Hintea T; Kiss R; Préda I; Kotevski V; Pejkov H; Dudek D; Heba G; Sylven C; Charwat S; Jacob R; Maurer G; Lang I; Glogar D Am Heart J; 2007 Feb; 153(2):212.e1-7. PubMed ID: 17239678 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-150 alleviates acute myocardial infarction through regulating cardiac fibroblasts in ventricular remodeling. Tian HB; Li SH; Hu KQ; Zan YS; Zhang XL; Su GH Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7611-7618. PubMed ID: 31539153 [TBL] [Abstract][Full Text] [Related]
35. Percutaneous intramyocardial delivery of mesenchymal stem cells induces superior improvement in regional left ventricular function compared with bone marrow mononuclear cells in porcine myocardial infarcted heart. Tao B; Cui M; Wang C; Ma S; Wu F; Yi F; Qin X; Liu J; Wang H; Wang Z; Ma X; Tian J; Chen Y; Wang J; Cao F Theranostics; 2015; 5(2):196-205. PubMed ID: 25553108 [TBL] [Abstract][Full Text] [Related]
36. Effect of Ischemic Preconditioning and Postconditioning on Exosome-Rich Fraction microRNA Levels, in Relation with Electrophysiological Parameters and Ventricular Arrhythmia in Experimental Closed-Chest Reperfused Myocardial Infarction. Spannbauer A; Traxler D; Lukovic D; Zlabinger K; Winkler J; Gugerell A; Ferdinandy P; Hausenloy DJ; Pavo N; Emmert MY; Hoerstrup SP; Jakab A; Gyöngyösi M; Riesenhuber M Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31052231 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction. Chen Y; Zhao Y; Chen W; Xie L; Zhao ZA; Yang J; Chen Y; Lei W; Shen Z Stem Cell Res Ther; 2017 Nov; 8(1):268. PubMed ID: 29178928 [TBL] [Abstract][Full Text] [Related]
38. Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction. Halkos ME; Zhao ZQ; Kerendi F; Wang NP; Jiang R; Schmarkey LS; Martin BJ; Quyyumi AA; Few WL; Kin H; Guyton RA; Vinten-Johansen J Basic Res Cardiol; 2008 Nov; 103(6):525-36. PubMed ID: 18704259 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of MiR-92a May Protect Endothelial Cells After Acute Myocardial Infarction in Rats: Role of KLF2/4. Liu H; Li G; Zhao W; Hu Y Med Sci Monit; 2016 Jul; 22():2451-62. PubMed ID: 27411964 [TBL] [Abstract][Full Text] [Related]
40. Prompt bone marrow-derived mesenchymal stem cell therapy enables early porcine heart function recovery from acute myocardial infarction. Fan CQ; Leu S; Sheu JJ; Zhen YY; Tsai TH; Chen YL; Chung SY; Chai HT; Sun CK; Yang JL; Chang HW; Ko SF; Yip HK Int Heart J; 2014; 55(4):362-71. PubMed ID: 24965596 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]